ScholarWorks@Gyeongsang National University

Browsing by Lim, Sung-NamAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 18 of 18

SCISCIESCOPUS
Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study

Lee, Je-Hwan; Kim, Yoo-Jin; Sohn, Sang Kyun; Yoon, Sung-Soo; Kim, Hawk; Cheong, June-Won; Lee, Won-Sik; Lee, Gyeong-Won; Lim, Sung-Nam; Kim, Min Kyoung, et al.

ArticleIssue Date2017CitationLEUKEMIA RESEARCH, v.60, pp 135 - 144PublisherPERGAMON-ELSEVIER SCIENCE LTD
SCIESCOPUS
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantationopen access

Kim, Seok Jin; Jo, Jae-Cheol; Yoon, Dok Hyun; Yang, Deok-Hwan; Yoon, Sang Eun; Lee, Gyeong-Won; Kong, Jee Hyun; Park, Yong; Kang, Ka-Won; Lee, Ho-Sup, et al.

ArticleIssue Date2023CitationFrontiers in Oncology, v.13PublisherFrontiers Media S.A.
SCIESCOPUS
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study

Kim, Do Young; Shin, Ho-Jin; Min, Chang-Ki; Eom, Hyeon-Seok; Jung, Jongheon; Kim, Kihyun; Lee, Jae Hoon; Yoo, Kwai Han; Lee, Ji Yun; Byun, Ja Min, et al.

ArticleIssue Date2023CitationClinical Lymphoma, Myeloma and Leukemia, v.23, pp S189 - S190PublisherCancer Media Group
SCISCIESCOPUS
Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload

Kim, Il-Hwan; Moon, Joon-Ho; Lim, Sung-Nam; Sohn, Sang-Kyun; Kim, Hoon-Gu; Lee, Gyeong-Won; Kim, Yang-Soo; Lee, Ho-Sup; Kwon, Ki-Young; Kim, Sung-Hyun, et al.

ArticleIssue Date2015CitationTRANSFUSION, v.55, no.7, pp 1613 - 1620PublisherWILEY
SCISCIESCOPUS
Fatal interstitial pneumonitis in a patient with relapsed diffuse large B cell lymphoma following yttrium-90 ibritumomab tiuxetan

Kim, Moon Jin; Lee, Gyeong-Won; Seo, Jong Woo; Kim, Hyun-Jung; Lim, Sung-Nam; Suh, Cheolwon

ArticleIssue Date2011CitationINVESTIGATIONAL NEW DRUGS, v.29, no.5, pp 1098 - 1101PublisherSPRINGER
SCISCIESCOPUS
High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era

Song, Moo-Kon; Yang, Deok-Hwan; Lee, Gyeong-Won; Lim, Sung-Nam; Shin, Seunghyeon; Pak, Kyoung June; Kwon, Seong Young; Shim, Hye Kyung; Choi, Bong-Hoi; Kim, In-Suk, et al.

ArticleIssue Date2016CitationLEUKEMIA RESEARCH, v.42, pp 1 - 6PublisherPERGAMON-ELSEVIER SCIENCE LTD
SCISCIESCOPUS
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Lim, Sung-Nam; Joo, Young-Don; Lee, Kyoo-Hyung; Kim, Dae-Young; Lee, Je-Hwan; Lee, Jung-Hee; Chi, Hyun-Sook; Yun, Sung-Cheol; Lee, Won Sik; Lee, Sang Min, et al.

ArticleIssue Date2015CitationAMERICAN JOURNAL OF HEMATOLOGY, v.90, no.11, pp 1013 - 1020PublisherWILEY-BLACKWELL
SCIESCOPUS
Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma

Park, Sungwoo; Jo, Jae-Cheol; Do, Young Rok; Yang, Deok-Hwan; Lim, Sung-Nam; Lee, Won-Sik; Kim, Won Seog; Lee, Ho Sup; Hong, Dae-Sik; Kim, Hyo Jung, et al.

ArticleIssue Date2019CitationCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.19, no.3, pp 149 - 156PublisherCIG MEDIA GROUP, LP
SCISCIESCOPUS
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemiaopen access

Kim, Dae-Young; Joo, Young-Don; Lim, Sung-Nam; Kim, Sung-Doo; Lee, Jung-Hee; Lee, Je-Hwan; Kim, Dong Hwan (Dennis); Kim, Kihyun; Jung, Chul Won; Kim, Inho, et al.

ArticleIssue Date2015CitationBLOOD, v.126, no.6, pp 746 - 756PublisherAMER SOC HEMATOLOGY
SCISCIESCOPUS
Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)open access

Jo, Jae-Cheol; Lee, Ho Sup; Suh, Cheolwon; Kang, Hye Jin; Kim, Won Seog; Eom, HyeonSeok; Kim, Inho; Shin, Ho-Jin; Park, Yong; Lee, Won Sik, et al.

ArticleIssue Date2019CitationBlood, v.134PublisherAmerican Society of Hematology
SCIESCOPUS
Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) studyopen access

Oh, Sung Yong; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Yoon, Dok Hyun; Yang, Deok-Hwan; Lee, Won Sik; Kim, Hyo Jung; Yhim, Ho-Young; Jeong, Seong Hyun, et al.

ArticleIssue Date2019CitationCANCER COMMUNICATIONS, v.39, no.1PublisherBMC
SCISCIESCOPUS
Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia

Lee, Je-Hwan; Kim, Hawk; Joo, Young-Don; Lee, Won-Sik; Bae, Sung Hwa; Zang, Dae Young; Kwon, Jihyun; Kim, Min Kyoung; Lee, Junglim; Lee, Gyeong Won, et al.

ArticleIssue Date2017CitationJOURNAL OF CLINICAL ONCOLOGY, v.35, no.24, pp 2754 - +PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 Study

Kim, Do Young; Min, Chang-Ki; Eom, Hyeon-Seok; Jung, Jongheon; Kim, Kihyun; Lee, Jae Hoon; Yoo, Kwai Han; Lee, Ji Yun; Byun, Ja Min; Kim, Sung-Hyun, et al.

ArticleIssue Date2025CitationClinical Lymphoma, Myeloma and Leukemia, v.25, no.12, pp 873 - 884PublisherCancer Media Group
SCOPUSESCIKCI
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea

Ahn, Seo-Yeon; Son, Sang Kyun; Lee, Gyu Hyung; Kim, Inho; Cheong, June-Won; Lee, Won Sik; Kim, Byung Soo; Jo, Deog-Yeon; Jung, Chul Won; Seong, Chu Myoung, et al.

ArticleIssue Date2022CitationBlood Research, v.57, no.2, pp 144 - 151Publisher대한혈액학회
SCIESCOPUS
Spectrum: Phase II Study of Tislelizumab Plus Pemetrexed in Patients with Relapsed or Refractory (R/R) Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): The Korean Cancer Study Group LY22-07

Kim, Tae Min; Kim, Jung Sun; Lee, Gyeong-Won; Lee, Myung-Won; Youk, Jeonghwan; Lee, Hyun Jung; Lim, Sung-Nam; Kim, Soyeon; Jeon, Yoon Kyung; Park, Chul-Kee, et al.

ArticleIssue Date2024CitationBlood, v.144, pp 3102 - 3103PublisherAmerican Society of Hematology
SCISCIESCOPUS
The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma

Lee, Gyeong-Won; Park, Sung Woo; Go, Se-Il; Kim, Hoon-Gu; Kim, Min Kyoung; Min, Chang-Ki; Kwak, Jae-Yong; Bae, Sang-Byung; Yoon, Sung-Soo; Lee, Je-Jung, et al.

ArticleIssue Date2018CitationACTA HAEMATOLOGICA, v.140, no.3, pp 146 - 156PublisherKARGER
SCISCIESCOPUS
Tumor necrosis could reflect advanced disease status in patients with diffuse large B cell lymphoma treated with R-CHOP therapy

Song, Moo-Kon; Chung, Joo-Seop; Shin, Dong-Yeop; Lim, Sung-Nam; Lee, Gyeong-won; Choi, Jae-Cheol; Park, Won-Young; Oh, So-Yeon

ArticleIssue Date2017CitationANNALS OF HEMATOLOGY, v.96, no.1, pp 17 - 23PublisherSPRINGER
SCIESCOPUS
Usefulness of spleen volume measured by computed tomography for predicting clinical outcome in primary myelofibrosis

Song, Moo-Kon; Chung, Joo-Seop; Lim, Sung-Nam; Lee, Gyeong-won; Lee, Sang-Min; Lee, Nam-Kyung; Choi, Jae-Cheol; Oh, So-Yeon

ArticleIssue Date2016CitationINTERNATIONAL JOURNAL OF HEMATOLOGY, v.104, no.4, pp 476 - 484PublisherSPRINGER JAPAN KK
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어